Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Palbociclib | 0.1 | uM | 3 | 2500.00 | 2418.67 | 3843.00 | 4356.25 | 0.8822 | 0.7254 |
SK-BR-3 | Methotrexate | 1 | uM | 3 | 2500.00 | 2418.67 | 2479.00 | 4356.25 | 0.5691 | 0.0295 |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4306.00 | 4356.25 | 0.9885 | 0.9729 | |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4419.00 | 4356.25 | 1.0144 | 1.0340 | |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4228.00 | 4356.25 | 0.9706 | 0.9308 | |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 3725.00 | 4356.25 | 0.8551 | 0.6632 | |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 3852.00 | 4356.25 | 0.8843 | 0.7302 | |
SK-BR-3 | Taxol | 0.00033113 | uM | 3 | 2500.00 | 2418.67 | 4497.00 | 4356.25 | 1.0323 | 1.0763 |
SK-BR-3 | Methotrexate | 0.01 | uM | 3 | 2500.00 | 2418.67 | 4452.00 | 4356.25 | 1.0220 | 1.0519 |
SK-BR-3 | Omipalisib | 1 | uM | 3 | 2500.00 | 2418.67 | 1659.00 | 4356.25 | 0.3808 | -0.3586 |
SK-BR-3 | Methotrexate | 10 | uM | 3 | 2500.00 | 2418.67 | 2629.00 | 4356.25 | 0.6035 | 0.1032 |
SK-BR-3 | Palbociclib | 1 | uM | 3 | 2500.00 | 2418.67 | 3153.00 | 4356.25 | 0.7238 | 0.3666 |
SK-BR-3 | Methotrexate | 0.31623 | uM | 3 | 2500.00 | 2418.67 | 2713.00 | 4356.25 | 0.6228 | 0.1449 |
SK-BR-3 | Taxol | 0.0031623 | uM | 3 | 2500.00 | 2418.67 | 3512.00 | 4356.25 | 0.8062 | 0.5517 |
SK-BR-3 | Methotrexate | 0.1 | uM | 3 | 2500.00 | 2418.67 | 3120.00 | 4356.25 | 0.7162 | 0.3498 |
SK-BR-3 | Omipalisib | 0.31623 | uM | 3 | 2500.00 | 2418.67 | 1715.00 | 4356.25 | 0.3937 | -0.3330 |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4354.00 | 4356.25 | 0.9995 | 0.9988 | |
SK-BR-3 | Palbociclib | 0.31623 | uM | 3 | 2500.00 | 2418.67 | 3538.00 | 4356.25 | 0.8122 | 0.5653 |
SK-BR-3 | Omipalisib | 0.01 | uM | 3 | 2500.00 | 2418.67 | 2783.00 | 4356.25 | 0.6389 | 0.1797 |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4466.00 | 4356.25 | 1.0252 | 1.0595 | |
SK-BR-3 | Omipalisib | 0.0033113 | uM | 3 | 2500.00 | 2418.67 | 3133.00 | 4356.25 | 0.7192 | 0.3564 |
SK-BR-3 | Taxol | 0.1 | uM | 3 | 2500.00 | 2418.67 | 1689.00 | 4356.25 | 0.3877 | -0.3449 |
SK-BR-3 | Taxol | 0.001 | uM | 3 | 2500.00 | 2418.67 | 4009.00 | 4356.25 | 0.9203 | 0.8136 |
SK-BR-3 | Palbociclib | 3.1623 | uM | 3 | 2500.00 | 2418.67 | 3211.00 | 4356.25 | 0.7371 | 0.3963 |
SK-BR-3 | Palbociclib | 0.031623 | uM | 3 | 2500.00 | 2418.67 | 3922.00 | 4356.25 | 0.9003 | 0.7673 |